CCL3 and chronic kidney disease: The elevation of MIP-1α was statistically significant in all diabetic groups (p = 0.003, p < 0.0001, p = 0.0002, and p < 0.0001 for CKD−, NA-CKD, A-CKD−, and A-CKD+ vs. control, respectively), demonstrating statistically significant differences between NA-CKD and CKD− patients (p = 0.0004).